- SAMHSA Updated FAQs for Opioid Use Disorder Prescribing and Dispensing During COVID-19 Emergency
- SAMHSA COVID-19 Guidance for Opioid Treatment Programs
- SAMHSA COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance
- MA DPH BSAS COVID-19 Order for Pharmacists and Administration of Medications to Treat Opioid Use Disorder (MOUD)
- MA DPH-BSAS Interim Guidance to Assist Opioid Treatment Programs (OTPs) with Provision of Medication
- MA DPH Guidance in Preventing and Mitigating COVID-19 in BSAS Licensed Programs
- COVID-19: Potential Implications for Individuals with Substance Use Disorders
- Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak
- COVID-19 Guidance for Clinicians and Opioid Treatment Programs
- Extended MA Health Connector Enrollment for Uninsured Individuals
- Managing Healthcare Workers’ Stress Associated with COVID-19 Virus Outbreak
- Massachusetts Executive Office of the Trial Court: Substance Use Disorder and Mental Health Resources
- Massachusetts Unemployment Insurance Guidance During the Coronavirus Outbreak
- Best Practices for Telehealth During COVID-19 Public Health Emergency
- Medication-Assisted Treatment (MAT) Guidance
- Center for Medicare & Medicaid Services COVID-19 Actions
- COVID-19 and Changes to Policies and Guidelines for Treating Substance Use Disorders